Cargando...
Progresses in clinical studies on antiviral therapies for COVID‐19—Experience and lessons in design of clinical trials
Antiviral therapy with antiviral agents is a very important component of treatment for the 2019 novel coronavirus disease (COVID‐19) caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). It is important to clarify how to evaluate efficacy and safety of antiviral agents in treat...
Guardado en:
| Publicado en: | Pediatr Investig |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7768300/ https://ncbi.nlm.nih.gov/pubmed/33376954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ped4.12227 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|